Innoviva Inc logo

Innoviva Inc

INVA
Healthcare|Biotechnology|USA
$22.23
+0.04 (+0.20%)
DCF (FCF)
$42.29
Tangible Book
$15.56
Graham Number
$41.06
Earnings Power
$26.78

Analyst Estimates

annual
{ "date": [ "202612", "202712", "202812", "202912", "203012" ], "revenue_estimate": [ 440.56, 483.98, 511.61, 568.87, 641.11 ], "ebit_estimate": [ 193.62, 207.16, 198.4, 199.04, 223 ], "ebitda_estimate": [ 252.62, 254.8, 237.52, null, null ], "net_income_estimate": [ 317.23, 178.06, 184.14, 194.68, 218.96 ], "per_share_eps_estimate": [ 3.87, 2.26, 1.79, 1.89, 2.09 ], "eps_nri_estimate": [ 3.98, 2.24, 2.05, 1.89, 2.09 ], "dividend_estimate": [ null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null ], "pretax_income_estimate": [ 387.65, 220.95, 233.08, 246.44, 277.17 ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null ], "roe_estimate": [ 15.7, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null ], "pettm_estimate": [ 5.75, 9.82, 12.42, 11.76, 10.64 ], "long_term_growth_rate_mean": -18.16, "long_term_revenue_growth_rate_mean": "7.77", "future_per_share_eps_estimate_growth": -21.1, "future_eps_nri_estimate_growth": -18.16, "future_revenue_estimate_growth": 7.77, "future_ebit_estimate_growth": 6.65, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -15.96, "future_pretax_income_estimate_growth": -14.59, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }
quarterly
{ "date": [ "202606", "202609", "202612", "202703", "202706", "202709", "202712" ], "revenue_estimate": [ 110.99, 113.48, 119.17, 119.28, 127.95, 127.1, 133.8 ], "ebit_estimate": [ 51.61, 50.37, 51.86, 51.51, 54.2, 52.4, 53.9 ], "ebitda_estimate": [ 69.65, 68.87, 65.91, 60.49, null, null, null ], "net_income_estimate": [ 27.86, 40.69, 43.06, 44.42, 46.29, 44.79, 46.73 ], "per_share_eps_estimate": [ 0.4, 0.5, 0.54, 0.56, 0.62, 0.61, 0.65 ], "eps_nri_estimate": [ 0.44, 0.51, 0.54, 0.53, 0.61, 0.6, 0.64 ], "dividend_estimate": [ null, null, null, null, null, null, null ], "book_value_per_share_estimate": [ null, null, null, null, null, null, null ], "pretax_income_estimate": [ 32.89, 50.2, 53.13, null, null, null, null ], "operating_cash_flow_per_share_estimate": [ null, null, null, null, null, null, null ], "roa_estimate": [ null, null, null, null, null, null, null ], "roe_estimate": [ null, null, null, null, null, null, null ], "gross_margin_estimate": [ null, null, null, null, null, null, null ], "operating_cash_flow_estimate": [ null, null, null, null, null, null, null ], "pettm_estimate": [ 11.19, 10.05, 9.59, 9.17, null, null, null ], "long_term_growth_rate_mean": -18.16, "long_term_revenue_growth_rate_mean": "7.77", "future_per_share_eps_estimate_growth": -21.1, "future_eps_nri_estimate_growth": -18.16, "future_revenue_estimate_growth": 7.77, "future_ebit_estimate_growth": 6.65, "future_ebitda_estimate_growth": null, "future_dividend_estimate_growth": null, "future_net_income_estimate_growth": -15.96, "future_pretax_income_estimate_growth": -14.59, "future_book_value_per_share_estimate_growth": null, "future_roa_estimate_growth": null, "future_roe_estimate_growth": null, "future_gross_margin_estimate_growth": null, "future_operating_cash_flow_per_share_estimate_growth": null }

News

2026-06-22 21:30:38
2026-06-18 13:00:27
2026-06-18 12:32:57
2026-06-16 13:02:20